Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1105 per EA under NDC 72888006305. Its NADAC has been published 148 times since Aug 30, 2023.
Strength
7.5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888006305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075521On Market Since
3/16/2021
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 148 times since Aug 30, 2023, and over the history we have for it it has declined 31.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1105 per EA |
|---|---|
| All-time high | $0.1623 (Sep 13, 2023) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1225 |
| 52-week low | $0.1105 |
| Median price | $0.1191 |
| Average price | $0.1206 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 148 |
| Tracking since | Aug 30, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1105 per EA (NDC 72888006305), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 31.9%. It has been tracked across 148 weekly CMS publications since Aug 30, 2023.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Aug 30, 2023, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.1623 (Sep 13, 2023), with a median of $0.1191 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 7.5 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 72888006305) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification